South Carolina General Assembly
120th Session, 2013-2014

Download This Version in Microsoft Word format

Bill 3823


Indicates Matter Stricken
Indicates New Matter


(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)

A BILL

TO AMEND SECTION 44-53-190, AS AMENDED, SECTIONS 44-53-210, 44-53-230, 44-53-250, AND 44-53-270, CODE OF LAWS OF SOUTH CAROLINA, 1976, RELATING, RESPECTIVELY, TO DRUGS DESIGNATED AS SCHEDULE I, II, III, IV, AND V CONTROLLED SUBSTANCES AND SECTION 44-53-1510, RELATING TO DRUGS DESIGNATED AS ANABOLIC STEROIDS, ALL SO AS TO ALPHABETIZE THESE LISTINGS AND TO ADD DRUGS TO THESE DESIGNATIONS TO CONFORM TO FEDERAL DRUG DESIGNATIONS AND DESIGNATIONS OF ADJACENT STATES IN ORDER TO ENHANCE AND IMPROVE ILLICIT DRUG ENFORCEMENT.

Be it enacted by the General Assembly of the State of South Carolina:

SECTION    1.        Section 44-53-190 of the 1976 Code, as last amended by Act 140 of 2012, is further amended to read:

"Section 44-53-190.    (A)    The controlled substances listed in this section are included in Schedule I.

(B)    Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

1. Acetylmethadol

2. Allylprodine

3. Alphacetylmethadol

4. Alphameprodine

5. Alphamethadol

6. Benzethidine

7. Betacetylmethadol

8. Betameprodine

9. Betamethadol

10. Betaprodine

11. Clonitazene

12. Dextromoramide

13. [Deleted]

14. Diampromide

15. Diethylthiambutene

16. Dimenoxadol

17. Dimepheptanol

18. Dimethylthiambutene

19. Dioxaphetyl butyrate

20. Dipipanone

21. Ethylmethylthiambutene

22. Etonitazene

23. Etoxeridine

24. Furethidine

25. Hydroxypethidine

26. Ketobemidone

27. Levomoramide

28. Levophenacylmorphan

29. Morpheridine

30. Noracymethadol

31. Norlevorphanol

32. Normethadone

33. Norpipanone

34. Phenadoxone

35. Phenampromide

36. Phenomorphan

37. Phenoperidine

38. Piritramide

39. Proheptazine

40. Properidine

41. Racemoramide

42. Trimeperidine

43. Propiram

44. Difenoxin

45. Alfentanyl

46. Tilidine

47. Alphamethylfentanyl (N-[1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl-4-(N-pro-panilido) piperidine).

1.        Acetyl-alpha-methylfentanyl

2.        Acetylmethadol

3.        Alfentanyl

4.        Alphamethylfentanyl (N-[1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl-4-(N-pro-panilido) piperidine)

5.        Alpha-methylthiofentanyl

6.        Allylprodine

7.        Alphacetylmethadol

8.        Alphameprodine

9.        Alphamethadol

10.    Benzethidine

11.    Betacetylmethadol

12.    Beta-hydroxyfentanyl

13.    Beta-hydroxy-3-methylfentanyl

14    Betameprodine

15.    Betamethadol

16.    Betaprodine

17.     Clonitazene

18.    Dextromoramide

19.    Diampromide

20.    Diethylthiambutene

21.    Difenoxin

22.    Dimenoxadol

23.    Dimepheptanol

24.    Dimethylthiambutene

25.    Dioxaphetyl butyrate

26.    Dipipanone

27.    Ethylmethylthiambutene

28.    Etonitazene

29.    Etoxeridine

30.    Furethidine

31.    Hydroxypethidine

32.    Ketobemidone

33.    Levomoramide

34.    Levophenacylmorphan

35.    3-Methylfentanyl

36.    1-Methyl-4-phenyl-4-propionoxypiperidine (MPPP)

37.    3-Methylthiofentanyl

38.    Morpheridine

39.    Noracymethadol

40.    Norlevorphanol

41.    Normethadone

42.    Norpipanone

43.    Para-Fluorofentanyl

44.    Phenadoxone

45.    Phenampromide

46.    1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine (PEPAP)

47.    Phenomorphan

48.    Phenoperidine

49.    Piritramide

50.    Proheptazine

51.    Properidine

52.    Propiram

53.    Racemoramide

54.    Thiofentanyl

55.    Tilidine

56.    Trimeperidine

(C)    Any of the following opium derivatives, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. Acetorphine

2. Acetyldihydrocodeine

3. Benzylmorphine

4. Codeine methylbromide

5. Codeine-N-Oxide

6. Cyprenorphine

7. Desomorphine

8. Dihydromorphine

9. Etorphine

10. Heroin

11. Hydromorphinol

12. Methyldesorphine

13. Methylhydromorphine

14. Morphine methylbromide

15. Morphine methylsulfonate

16. Morphine-N-Oxide

17. Myrophine

18. Nicocodeine

19. Nicomorphine

20. Normorphine

21. Pholcodine

22. Thebacon

23. Drotebanol

1. Acetorphine

2. Acetyldihydrocodeine

3. Benzylmorphine

4. Codeine methylbromide

5. Codeine-N-Oxide

6. Cyprenorphine

7. Desomorphine

8. Dihydromorphine

9. Drotebanol

10. Etorphine

11. Heroin

12. Hydromorphinol

13. Methyldesorphine

14. Methylhydromorphine

15. Morphine methylbromide

16. Morphine methylsulfonate

17. Morphine-N-Oxide

18. Myrophine

19. Nicocodeine

20. Nicomorphine

21. Normorphine

22. Pholcodine

23. Thebacon

(D)    Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1. 3,4-methylenedioxy amphetamine

2. 5-methoxy-3,4-methylenedioxy amphetamine

3. 3,4-methylenedioxymethamphetamine (MDMA)

4. 3,4,5-trimethoxy amphetamine

5. Bufotenine

6. Diethyltryptamine (DET)

7. Dimethyltryptamine (DMT)

8. 4-methyl-2,5-dimethoxyamphetamine (STP)

9. Ibogaine

10. Lysergic acid diethylamide (LSD)

11. Marijuana

12. Mescaline

13. Peyote

14. N-ethyl-3-piperidyl benzilate

15. N-methyl-3-piperidyl benzilate

16. Psilocybin

17. Psilocyn

18. Tetrahydrocannabinol (THC)

19. 2,5-dimethoxyamphetamine

20. 4-bromo-2,5-dimethoxyamphetamine

21. 4-Methoxyamphetamine

22. Thiophene analog of phencyclidine

23. Parahexyl

24. Synthetic cannabinoids.--Any material, compound, mixture, or preparation that is not listed as a controlled substance in Schedule I through V, is not an FDA-approved drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues, and salts of isomers and homologues, unless specifically excepted, whenever the existence of these salts, isomers, homologues, and salts of isomers and homologues is possible within the specific chemical designation:

a. Naphthoylindoles. Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-398, AM-2201, WIN 55-212, AM-2201 (C1 analog), AM-1220.

b. Naphthylmethylindoles. Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.

c. Naphthoylpyrroles. Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-307, JWH-370, JWH-176.

d. Naphthylmethylindenes. Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.

e. Phenylacetylindoles. Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, SR-18, RCS-8, JWH-203, JWH-250, JWH-251.

f. Cyclohexylphenols. Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to, CP 47,497 (and homologues), cannabicyclohexanol, CP-55, 940.

g. Benzoylindoles. Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, AM-694, Pravadoline (WIN 48,098), RCS-4, AM-630, AM-1241, AM-2233.

h. 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-de]-1, 4-benzoxazin-6-yl]-1-napthalenylmethanone (WIN 55,212-2).

i. 9-(hydroxymethyl)-6,6-dimethy l-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol 7370 (HU-210, HU-211).

j. Adamantoylindoles. Any compound containing a 3-(1-adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring system to any extent.

(E) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substance having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers if possible within the specific chemical designation:

(1) Mecloqualone;

(2) Methaqualone; or

(3) Gamma Hydroxybutyric Acid.

(F) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

(1) Fenethylline;

(2) N-ethylamphetamine;

(3) Cathinone; or

(4) Substituted Cathinones.

Any compound (not being bupropion) structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways:

(a) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;

(b) by substitution at the 3-position with an alkyl substituent;

(c) by substitution at the nitrogen atom with alkyl or dialkyl groups, benzyl or methoxybenzyl groups; or

(d) by inclusion of the nitrogen atom in a cyclic structure.

Including, but not limited to: Methylone, Mephedrone, 3,4-Methylenedioxypyrovalerone (MDPV), Butylone, Methedrone, 4-Methylethcathinone, Flephedrone, Pentylone, Pentedrone, Buphedrone.

1.        Alpha-ethyltryptamine (alpha-ET)

2.        Alpha-methyltryptamine (AMT)

3.        4-bromo-2,5-dimethoxyamphetamine

4.        4-Bromo-2,5-dimethoxyphenethylamine (2C-B)

5.        Bufotenine

6.        2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)

7.        Cyclohexamine (Ethylamine analog of phencyclidine, PCE)

8.        Diethyltryptamine (DET)

9.        2,5-Dimethoxy-4-chloroamphetamine (DOC)

10.    2,5-Dimethoxy-4-iodoamphetamine (DOI)

11.    2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)

12.    2,5-Dimethoxy-4-methylthiophenethylamine (2C-T)

13. 2,5-dimethoxyamphetamine

14.    2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E)

15.    2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)

16.    2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)

17.    2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N)

18.    2-(2,5-Dimethoxy-4-(n)-prophylphenyl) ethanamine (2C-P)

19.    2-(4-ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2)

20.    2-(4-ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-4)

21.    2,5-Dimethoxy-4-(n)propylthiophenethylamine (2C-T-7)

22.    2,5-Dimethoxy-4-ethylamphetamine (DOE)

23.     Dimethyltryptamine (DMT)

24.    5-Hydroxy-alpha-methyltryptamine (5-HO-aMT)

25.    5-Hydroxy-N-methyltryptamine (N-methylserotonin, norbufotenin)

26.    4-Hydroxy-N,N-diisopropyltryptamine (4-HO-DiPT)

27.    4-hydroxy-N-methyl-N-ethyltryptamine (4-HO-MET)

28.    Ibogaine

29.    4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25-I-NBOMe)

30.    5-Iodo-2-aminoindane (5-IAI)

31.    Lysergic acid diethylamide (LSD)

32.    Marijuana

33.    Mescaline

34.    Methoxetamine (MXE)

35.    5-Methoxy-alpha-methyltryptamine (5-MeO-AMT)

36.    4-Methoxyamphetamine

37.    3-Methoxy-4,5-methylenedioxyamphetamine (MMDA)

38.    5-Methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT, Moxy, Moxie)

39.    5 Methoxy-N,N,Dimethyltryptamine (5-MeO-DMT)

40.    5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT)

41.    4-Methoxyphencyclidine (4-MeO-PCP, Methoxydine)

42.    4-Methyl-alpha-ethyltryptamine (4-methyl-aET)

43.    Methylbenzodioxolybutanamine (MBDB)

44.    4-Methyl-2,5-dimethoxyamphetamine (STP)

45.    3,4-Methylenedioxyamphetamine (MDA)

46.    3,4-Methylenedioxy-N-ethylamphetamine (MDEA)

47.    5,6-Methylenedioxy-2-aminoindane (MDAI)

48.    3,4-Methylenedioxymethamphetamine (MDMA)

49.    5-Methyl-N,N-dimethyltryptamine (5-Me-DMT)

50.    N-Ethyl-1-phenylcyclohexylamine (Eticyclidine)

51.    N-ethyl-3-piperidyl benzilate

52.    N-Hydroxy-3,4-methylenedioxyamphetamine (N-hydroxy MDA)

53.    N-methyl-3-piperidyl benzilate

54.    N-Methyltryptamine (Methyltryptamine, NMT)

55.    N,N-diallyl-5-methoxytryptamine (5-MeO-DALT)

56.    N,N-Diisopropyltryptamine(DiPT)

57.    N,N-Dipropyltryptamine(DPT)

58.    Parahexyl

59.    Peyote

60.    Psilocybin

61.    Psilocyn

62.    Rolicyclidine (Pyrrolidine analog of phencyclidine ,PHP, PCPy)

63.    Synthetic cannabinoids.    Any material, compound, mixture, or preparation that is not listed as a controlled substance in Schedule I through V, is not an FDA-approved drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues, and salts of isomers and homologues, unless specifically excepted, whenever the existence of these salts, isomers, homologues, and salts of isomers and homologues is possible within the specific chemical designation:

a.    Adamantoylindoles.    Any compound containing a 3-(1-adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring system to any extent.

b.    Benzoylindoles. Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, AM-694, Pravadoline (WIN 48,098), RCS-4, AM-630, AM-1241, AM-2233.

c.    Cyclohexylphenols. Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to, CP 47,497 (and homologues), cannabicyclohexanol, CP-55, 940.

d.    2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-

napthalenylmethanone (WIN 55,212-2).

e.    4-[4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl]-6,6-dimethyl-bicyclo[3.1.1] hept-2-ene-2-methanol (HU-308).

f.    (6aR,9R,10aR)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydrobenzo [c]chromene-1,9-diol (HU-243, Canbisol).

g. 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione (HU-331)

h.    [(6S,6aR, 9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate (Levantradol, CP 50,556-1).

i.    9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol 7370 (HU-210, HU-211).

j.    Indazole-3-carboxamides. Any compound containing an Indazole-3-carboxamide structure with substitution at the nitrogen atom of the indazole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring to any extent. Including, but not limited, to AKB-48, AB-FUBINACA, AB-PINACA.

k.    Indole -3-carboxamides. Any compound containing an Indole-3-carboxamide structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring to any extent. Including, but not limited, to STS-135.

l.    Indole - 3-ylcycloalkyl ketones. Any compound containing an Indole-3-ylcycloalkyl ketone structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent or whether or not substituted at the cycloalkyl ring to any extent. Including, but not limited to, XLR-11, UR-144, A-834735, A-796260, AB-001, AB-005.

m.    1-napthalenyl[4-(pentylox)-1-napthalenyl]-methanone (CB-13, CRA-13).

n.    Naphthoylindoles. Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-398, AM-2201, WIN 55-212, AM-2201 (C1 analog), AM-1220.

o.    Naphthoylpyrroles. Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-307, JWH-370, JWH-176.  

p.    Naphthylmethylindoles. Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.

q.    Naphthylmethylindenes. Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.

r.    N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-undecanamide (CB-25).

s.    N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-undecanamide (CB-52).

t.    N-cyclopropyl-8-[3-(1,1-dimethylheptyl)-5-hydroxyphenoxy]-octanamide (CB-86).

u.    Phenylacetylindoles. Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, SR-18, RCS-8, JWH-203, JWH-250, JWH-251.

64.    Tenocyclidine(1-[1-(2-Thienyl)cyclohexyl]piperidine, TCP)

65.    Tetrahydrocannabinol (THC)

66.    1-[1-(2-Thienyl)cyclohexyl]pyrrolidine (TCPy)

67.    Thiophene analog of phencyclidine

68.    3,4,5-trimethoxy amphetamine

(E)    Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substance having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers if possible within the specific chemical designation:

1.    Gamma Hydroxybutyric Acid

2.    Mecloqualone

3. Methaqualone

(F)    Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:

1.        2-Aminoindane (2-AI)

2.        6-(2-aminopropyl)benzofuran (6-APB)

3.        Aminorex

4.        Benocyclidine (BCP, BTCP)

5.        Cathinone  

6.        4-Chlorophenylisobutylamine (4-CAB)

7.        3-Chlorophenylpiperazine (mCPP)

8.        4-Chlorophenylpiperazine (pCPP)

9.        1,4-Dibenzylpiperazine (DBZP)

10.    Fenethylline

11.    4-Fluoroamphetamine (4-FA)

12.    2-Fluoromethamphetamine (2-FMA)

13.    4-Fluoromethamphetamine (4-FMA)

14.    4-Fluorophenylpiperazine (pFPP)

15.    Methiopropamine (MPA)

16.    2-Methoxyphenylpiperazine (oMeOPP)

17.    4-Methoxyphenylpiperazine (pMeOPP)

18.    4-Methylaminorex (cis isomer)

19.    1-Methyl-4-benzyl piperazine (MBZP)

20.    3,4-Methylenedioxy-1-benzylpiperazine (MDBZP)

21.    3-Methylphenylpiperazine (mMPP)

22.    4-Methylphenylpiperazine (pMPP)

23.    N-Benzylpiperazine (BZP)

24.    N-ethylamphetamine

25.    N,N-Dimethylamphetamine (Metrotonin)

26.    Substituted Cathinones

Any compound (not being bupropion) structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways:

(a)    by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;

(b)    by substitution at the 3-position with an alkyl substituent;

(c)    by substitution at the nitrogen atom with alkyl or dialkyl groups, benzyl or methoxybenzyl groups, or alkanoyl groups; or

(d)    by inclusion of the nitrogen atom in a cyclic structure.

Including, but not limited to: Methylone, Mephedrone, 3,4-Methylenedioxypyrovalerone (MDPV), Butylone, Methedrone, 4-Methylethcathinone, Flephedrone, Pentylone, Pentedrone, Buphedrone.

27.    3-Trifluoromethylphenylpiperazine (TFMPP)"

SECTION    2.    Section 44-53-210 of the 1976 Code is amended to read:

"Section 44-53-210.    (a)    The controlled substances listed in this section are included in Schedule II.

(b)    Any of the following substances except those narcotic drugs listed in other schedules whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by combination of extraction and chemical synthesis:

(1)    Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding Apomorphine, Nalbuphine, Naloxone, and Naltrexone, and their respective salts;

(2)    Any salt, compound, isomer, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (1), but not including the isoquinoline alkaloids of opium;

(3)    Opium poppy and poppy straw;

(4)    Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions which do not contain cocaine or ecgonine.

(c)    Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

1. Alphaprodine

2. Anileridine

3. Bezitramide

4. Dihydrocodeine

5. Diphenoxylate

6. Fentanyl

7. Isomethadone

8. Levomethorphan

9. Levorphanol

10. Metazocine

11. Methadone

12. Methadone - Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane

13. Moramide - Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid

14. Pentazocine (to be administered by injection only)

15. Pethidine (meperidine).

16. Pethidine - Intermediate-A, 4-cyano-1-methyl-4-phenyl-piperidine

17. Pethidine - Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate

18. Pethidine - Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid

19. Phenazocine

20. Piminodine

21. Racemethorphan

22. Racemorphan

23. Dextropropoxyphene [alpha-(+" )-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane], in bulk form.

24. Sufentanil

1.    Alfentanil

2.    Alphaprodine

3. Anileridine

4.    4-Anilino-N-phenethyl-4-piperidine

5.    Bezitramide

6.    Dextropropoxyphene[alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane], in bulk form

7.        Dihydrocodeine

8.        Dihydroetorphine

9.        Diphenoxylate

10.    Diprenorphine

11.    Fentanyl

12.    Isomethadone

13.    Levo-alphacetylmethadol

14.    Levomethorphan

15.    Levorphanol

16.    Metazocine

17.    Methadone

18.    Methadone - Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane

19.    Moramide - Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid

20.    Oripavine

21.    Oxycodone

22.    Pentazocine (to be administered by injection only)

23.    Pethidine (meperidine).

24.    Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenyl-piperidine

25.    Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate

26.    Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid

27.    Phenazocine

28.    Piminodine

29.    Racemethorphan

30.    Racemorphan

31.    Remifentanil

32.    Sufentanil

33.    Tapentadol

34.    Thebaine

(d)    Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:

1. Amphetamine, its salts, optical isomers, and salts of its optical isomers.

2. Methamphetamine, its salts, and salts of isomers.

3. Phenmetrazine and its salts.

4. Methylphenidate.

2.    Lisdexamfetamine

3.    Methamphetamine, its salts, and salts of isomers

4.    Methylphenidate

5.    Phenmetrazine and its salts

(e)    [Deleted] Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1.    Nabilone

(f)    Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:

1.    Amobarbital

2. Secobarbital

3. Pentobarbital

4. Phencyclidine

5. Phencyclidine immediate precursors:

(a) 1-phenylcyclohexylamine

(b) 1-piperidinocyclohexanecarbonitrile (PCC).

2.    Pentobarbital

3.    Phencyclidine

4.    Phencyclidine immediate precursors

(a)    1-phenylcyclohexylamine

(b)    1-piperidinocyclohexanecarbonitrile (PCC)

5.    Secobarbital

(g)    Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substance:

(1)    Immediate precursor to amphetamine and methamphetamine:

(i)    Phenylacetone, also known as phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone."

SECTION    3.    Section 44-53-230 of the 1976 Code is amended to read:

"Section 44-53-230.    (a)    The controlled substances listed in this section are included in Schedule III.

(b)    Any material, compound, mixture or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:

1. Benzphetamine

2. Chlorphentermine

3. Clortermine

4. (Deleted)

5. Phendimetrazine

(c)    Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:

1.    any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital or any salt thereof and one or more other active ingredients which are not listed in any schedule;

2.    any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs and approved by the United States Food and Drug Administration for marketing only as a suppository;

3.    any substance which contains any quantity of a derivative or barbituric acid or any salt thereof;

4.    Chlorhexadol;

5. Gamma Hydroxybutyric Acid, and its salts, isomers, and salts of isomers contained in a drug product for which an application has been approved under Section 505 of the Federal Food, Drug and Cosmetic Act;

6. Glutehimide;

7. Lysergic Acid;

8. Lysergic Acid Amide;

9. Methyprylon;

10. Sulfondiethylmethane;

11. Sulfonethylmethane;

12. Sulfonmethane.

5.    Embutramide

6.    Gamma Hydroxybutyric Acid, and its salts, isomers, and salts of isomers contained in a drug product for which an application has been approved under Section 505 of the Federal Food, Drug and Cosmetic Act;

7.        Glutethimide;

8.        Ketamine;

9.        Lysergic Acid;

10.    Lysergic Acid Amide;

11.    Methyprylon;

12.    Sulfondiethylmethane;

13.    Sulfonethylmethane;

14.    Sulfonmethane;

15.    Tiletamine & Zolazepam Combination Product.

(d)    Nalorphene.

(e)    Any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:

1.    not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium.;

2.    not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic nonnarcotic ingredients in recognized therapeutic amounts.;

3.    not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a four-fold or greater quantity of an isoquinoline alkaloid of opium.;

4.    not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic nonnarcotic ingredients in recognized therapeutic amounts.;

5.    not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic nonnarcotic ingredients in recognized therapeutic amounts.;

6.    not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic nonnarcotic ingredients in recognized therapeutic amounts.;

7.    not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, non-narcotic nonnarcotic ingredients in recognized therapeutic amounts.;

8.    not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with one or more active, non-narcotic nonnarcotic ingredients in recognized therapeutic amounts.;

9.        Buprenorphine;

10.    o-Desmethyltramadol;

11.    Tramadol;

(f)    Dronabinol in sesame oil and encapsulated in a soft gelatin capsule."

SECTION    4.    Section 44-53-250 of the 1976 Code is amended to read:

"Section 44-53-250.    The controlled substances in this section are included in Schedule IV.

(a)    Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers (whether position, geometric, or optical), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1) Alprazolam

(2) Barbital

(3) Bromazepam

(4) Camazepam

(5) Chloral Betaine

(6) Chloral Hydrate

(7) Chlordiazepoxide

(8) Clobazam

(9) Clonazepam

(10) Clorazepate

(11) Clotiazepam

(12) Cloxazolam

(13) Delorazepam

(14) Diazepam

(15) Estazolam

(16) Ethchlorvynol

(17) Ethinamate

(18) Ethyl Loflazepate

(19) Fludiazepam

(20) Flunitrazepam

(21) Flurazepam

(22) Halazepam

(23) Haloxazolam

(24) Ketazolam

(25) Loprazolam

(26) Lorazepam

(27) Lormetazepam

(28) Mebutamate

(29) Medazepam

(30) Meprobamate

(31) Methohexital

(32) Methylphenobarbital

(33) Nimetazepam

(34) Nitrazepam

(35) Nordiazepam

(36) Oxazepam

(37) Oxazolam

(38) Paraldehyde

(39) Petrichloral

(40) Phenobarbital

(41) Pinazepam

(42) Prazepam

(43) Temazepam

(44) Tetrazepam

(45) Triazolam.

1.        Alprazolam

2.        Barbital

3.        Bromazepam

4.        Camazepam

5.        Chloral Betaine

6.        Chloral Hydrate

7.        Chlordiazepoxide

8.        Clobazam

9.        Clonazepam

10.    Clorazepate

11.    Clotiazepam

12.    Cloxazolam

13.    Delorazepam

14.    Diazepam

15.    Dichloralphenazone

16.    Estazolam

17.    Ethchlorvynol

18.    Etizolam

19.    Ethinamate

20.    Ethyl Loflazepate

21.    Fludiazepam

22.    Flunitrazepam

23.    Flurazepam

24.    Fospropofol

25.    Halazepam

26.    Haloxazolam

27.    Ketazolam

28.    Loprazolam

29.    Lorazepam

30.    Lormetazepam

31.    Mebutamate

32.    Medazepam

33.    Meprobamate

34.    Methohexital

35.    Methylphenobarbital

36.    Midazolam

37.    Nimetazepam

38.    Nitrazepam

39.    Nordiazepam

40.    Oxazepam

41.    Oxazolam

42.    Paraldehyde

43.    Petrichloral

44.    Phenazepam

45.    Phenobarbital

46.    Pinazepam

47.    Prazepam

48.    Pyrazolam

49.    Quazepam

50.    Temazepam

51.    Tetrazepam

52.    Triazolam.

53.    Zaleplon

54.    Zolpidem

55.    Zopiclone

(b)    Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether position, geometric, or optical), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1) Diethylpropion

(2) Mazindol

(3) Phentermine

(4) Pemoline, including organometallic complexes and chelates thereof

(5) Pipradol

(6) SPA [(-)-1-Dimethylamino-1, 2-diphenylethane].

1.        Cathine

2.        Diethylpropion

3.        Fencamfamin

4.        Fenproporex

5.        Mazindol

6.        Mefenorex

7.        Modafinil

8.        Phentermine

9.        Pemoline, including organometallic complexes and chelates thereof

10.    Pipradol

11.    Sibutramine.

12.    SPA [(-)-1-Dimethylamino-1, 2-diphenylethane]

(c)    Any material, compound, mixture or preparation containing any quantity of the following substance, including its salts, isomers (whether position, geometric, or optical) and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible:

(1)    Fenfluramine.

(d)    Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts;:

(1)    [Blank] (Reserved)

(e)    Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:

(1)    not more than one milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit.

(2)    dosage forms of Dextropropoxyphene [Alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane].

(f)    Pentazocine hydrochloride and acetaminophen, pentazocine hydrochloride and aspirin, and pentazocine and naloxone hydrochloride (all for oral administration only).

(g)    Butorphanol"

SECTION    5.    Section 44-53-270 of the 1976 Code is amended to read:

"Section 44-53-270.    (a)    The controlled substances listed in this section are included in Schedule V.

(b)    Any compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, which shall include includes one or more non-narcotic nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation, valuable medicinal qualities other than those possessed by the narcotic drug alone:

(1)    not more than 200 milligrams of codeine per 100 milliliter or per 100 grams;

(2)    not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;

(3)    not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;

(4)    not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit;

(5)    not more than 100 milligrams of opium per 100 milliliters or per 100 grams.;

(6)    not more than one-half milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit.

(c)    Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers (whether position, geometric, or optical), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1.        Lacosamide

2.        Pregabalin

(d)    Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether position, geometric, or optical), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

1.     Pyrovalerone"

SECTION    6.    Section 44-53-1510 of the 1976 Code is amended to read:

"Section 44-53-1510.    (A)    The term 'anabolic steroid' includes any of the following or any isomer, ester, salt, or derivative of the following that acts in the same manner on the human body:

(1) clostebol;

(2) dehydrochlormethyltestosterone;

(3) ethylestrenol;

(4) fluoxymesterone;

(5) mesterolone;

(6) methandienone;

(7) methandrostenolone;

(8) methenolone;

(9) methyltestosterone;

(10) nandrolone;

(11) norethandrolone;

(12) oxandrolone;

(13) oxymesterone;

(14) oxymetholone;

(15) stanozolol; and

(16) testosterone.

1.        3-alpha,17beta-dihydroxy-5alpha-androstane

2.        17-alpha-methyl-3alpha,17beta-dihydroxy-5alpha-androstane

3.        17-alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane

4.        17-alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene

5.        17-alpha-methyl-4-hydroxynandrolone

6.        17-alpha-methyl-delta1-dihydrotestosterone

7.        androstanedione

8.        1-androstenediol

9.        4-androstenediol

10.    5-androstenediol

11.    1-androstenedione

12.    4-androstenedione

13.    5-androstenedione

14.    3-beta,17beta-dihydroxy-5alpha-androstane

15.    13-beta-ethyl-17beta-hydroxygon-4-en-3-one

16.    bolasterone

17.    boldenone

18.    boldione

19.    calusterone

20.    clostebol

21.    dehydrochlormethyltestosterone

22.    delta1-dihydrotestosterone

23.    desoxymethyltestosterone

24.    4-dihydrotestosterone

25.    drostanolone

26.    ethylestrenol

27.    fluoxymesterone

28.    formebolone

29.    furazabol

30.    4-hydroxy-19-nortestosterone

31.    4-hydroxytestosterone

32.    mestanolone

33.    esterolone

34.    methandienone

35.    methandriol

36.    methandrostenolone

37.    methenolone

38.    methyldienolone

39.    methyltestosterone

40.    methyltrienolone

41.    mibolerone

42.    nandrolone

43.    19-nor-4,9(10)-androstadienedione

44.    19-nor-4-androstenediol

45.    19-nor-4-androstenedione

46.    19-nor-5-androstenediol

47.    19-nor-5-androstenedione

48.    norbolethone

49.    norclostebol

50.    norethandrolone

51.    normethandrolone

52.    oxandrolone;

53.    oxymesterone

54.    oxymetholone

55.    prostanozol

56.    stanozolol

57.    stenbolone

58.    testolactone

59.    testosterone

60.    tetrahydrogestrinone

61.    trenbolone

(B)    Anabolic steroids that are expressly intended for administration through implants to cattle or other nonhuman species, and that are approved by the federal Food and Drug Administration for this use, are not considered anabolic steroids as defined by this article and are not governed by its provisions."

SECTION    7.    This act takes effect upon approval by the Governor.

----XX----

This web page was last updated on March 19, 2013 at 1:01 PM